Certara, Inc. (NASDAQ: CERT) Stock Competitors & Peer Comparison
See CERT's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for CERT and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CERT | $6.85 | -1.30% | 1.1B | 17.56 | $0.39 | N/A |
| VEEV | $189.24 | -4.14% | 30.7B | 22.71 | $8.33 | N/A |
| GEHC | $62.04 | -1.26% | 28.2B | 13.61 | $4.56 | +0.23% |
| GEHCV | $56.00 | -4.08% | 25.5B | N/A | N/A | N/A |
| BTSGU | $239.04 | +3.24% | 14.4B | 216.59 | $1.11 | N/A |
| BTSG | $72.56 | +2.92% | 14.2B | 58.52 | $1.24 | N/A |
| SGFY | $30.49 | +0.07% | 8.9B | 70.91 | $0.43 | N/A |
| TEM | $48.98 | +1.18% | 8.5B | -97.96 | -$0.50 | N/A |
| HQY | $97.77 | -1.12% | 8.2B | 22.84 | $4.28 | N/A |
| HNGE | $84.35 | -3.82% | 6.5B | 43.22 | $1.95 | N/A |
Stock Comparison
Veeva Systems Inc. (NYSE: VEEV)
CERT vs VEEV Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, VEEV has a market cap of 30.7B. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while VEEV trades at $189.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas VEEV's P/E ratio is 22.71. In terms of profitability, CERT's ROE is -0.01%, compared to VEEV's ROE of +0.13%. Regarding short-term risk, CERT is less volatile compared to VEEV. This indicates lower risk in terms of short-term price fluctuations for CERT.Check VEEV's competition here
GE HealthCare Technologies Inc. (NASDAQ: GEHC)
CERT vs GEHC Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, GEHC has a market cap of 28.2B. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while GEHC trades at $62.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas GEHC's P/E ratio is 13.61. In terms of profitability, CERT's ROE is -0.01%, compared to GEHC's ROE of +0.15%. Regarding short-term risk, CERT is more volatile compared to GEHC. This indicates higher risk in terms of short-term price fluctuations for CERT.Check GEHC's competition here
GE HealthCare Technologies Inc. (NASDAQ: GEHCV)
CERT vs GEHCV Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, GEHCV has a market cap of 25.5B. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while GEHCV trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas GEHCV's P/E ratio is N/A. In terms of profitability, CERT's ROE is -0.01%, compared to GEHCV's ROE of +0.19%. Regarding short-term risk, CERT is less volatile compared to GEHCV. This indicates lower risk in terms of short-term price fluctuations for CERT.Check GEHCV's competition here
BrightSpring Health Services, Inc. Tangible Equity Unit (NASDAQ: BTSGU)
CERT vs BTSGU Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, BTSGU has a market cap of 14.4B. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while BTSGU trades at $239.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas BTSGU's P/E ratio is 216.59. In terms of profitability, CERT's ROE is -0.01%, compared to BTSGU's ROE of +0.17%. Regarding short-term risk, CERT is more volatile compared to BTSGU. This indicates higher risk in terms of short-term price fluctuations for CERT.Check BTSGU's competition here
BrightSpring Health Services, Inc. Common Stock (NASDAQ: BTSG)
CERT vs BTSG Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, BTSG has a market cap of 14.2B. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while BTSG trades at $72.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas BTSG's P/E ratio is 58.52. In terms of profitability, CERT's ROE is -0.01%, compared to BTSG's ROE of +0.17%. Regarding short-term risk, CERT is more volatile compared to BTSG. This indicates higher risk in terms of short-term price fluctuations for CERT.Check BTSG's competition here
Signify Health, Inc. (NYSE: SGFY)
CERT vs SGFY Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, SGFY has a market cap of 8.9B. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while SGFY trades at $30.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas SGFY's P/E ratio is 70.91. In terms of profitability, CERT's ROE is -0.01%, compared to SGFY's ROE of -0.15%. Regarding short-term risk, CERT is more volatile compared to SGFY. This indicates higher risk in terms of short-term price fluctuations for CERT.Check SGFY's competition here
Tempus AI, Inc. (NASDAQ: TEM)
CERT vs TEM Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, TEM has a market cap of 8.5B. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while TEM trades at $48.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas TEM's P/E ratio is -97.96. In terms of profitability, CERT's ROE is -0.01%, compared to TEM's ROE of -0.70%. Regarding short-term risk, CERT is less volatile compared to TEM. This indicates lower risk in terms of short-term price fluctuations for CERT.Check TEM's competition here
HealthEquity, Inc. (NASDAQ: HQY)
CERT vs HQY Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, HQY has a market cap of 8.2B. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while HQY trades at $97.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas HQY's P/E ratio is 22.84. In terms of profitability, CERT's ROE is -0.01%, compared to HQY's ROE of +0.11%. Regarding short-term risk, CERT is more volatile compared to HQY. This indicates higher risk in terms of short-term price fluctuations for CERT.Check HQY's competition here
Hinge Health, Inc. (NYSE: HNGE)
CERT vs HNGE Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, HNGE has a market cap of 6.5B. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while HNGE trades at $84.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas HNGE's P/E ratio is 43.22. In terms of profitability, CERT's ROE is -0.01%, compared to HNGE's ROE of -1.39%. Regarding short-term risk, CERT is less volatile compared to HNGE. This indicates lower risk in terms of short-term price fluctuations for CERT.Check HNGE's competition here
R1 RCM Inc. (NASDAQ: RCM)
CERT vs RCM Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, RCM has a market cap of 6B. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while RCM trades at $14.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas RCM's P/E ratio is -102.21. In terms of profitability, CERT's ROE is -0.01%, compared to RCM's ROE of +0.00%. Regarding short-term risk, CERT is more volatile compared to RCM. This indicates higher risk in terms of short-term price fluctuations for CERT.Check RCM's competition here
10x Genomics, Inc. (NASDAQ: TXG)
CERT vs TXG Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, TXG has a market cap of 6B. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while TXG trades at $47.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas TXG's P/E ratio is -277.65. In terms of profitability, CERT's ROE is -0.01%, compared to TXG's ROE of -0.03%. Regarding short-term risk, CERT is less volatile compared to TXG. This indicates lower risk in terms of short-term price fluctuations for CERT.Check TXG's competition here
Doximity, Inc. (NYSE: DOCS)
CERT vs DOCS Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, DOCS has a market cap of 3.9B. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while DOCS trades at $21.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas DOCS's P/E ratio is 13.79. In terms of profitability, CERT's ROE is -0.01%, compared to DOCS's ROE of +0.19%. Regarding short-term risk, CERT is less volatile compared to DOCS. This indicates lower risk in terms of short-term price fluctuations for CERT.Check DOCS's competition here
1Life Healthcare, Inc. (NASDAQ: ONEM)
CERT vs ONEM Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, ONEM has a market cap of 3.4B. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while ONEM trades at $16.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas ONEM's P/E ratio is -7.77. In terms of profitability, CERT's ROE is -0.01%, compared to ONEM's ROE of -0.24%. Regarding short-term risk, CERT is less volatile compared to ONEM. This indicates lower risk in terms of short-term price fluctuations for CERT.Check ONEM's competition here
Privia Health Group, Inc. (NASDAQ: PRVA)
CERT vs PRVA Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, PRVA has a market cap of 3.3B. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while PRVA trades at $26.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas PRVA's P/E ratio is 164.44. In terms of profitability, CERT's ROE is -0.01%, compared to PRVA's ROE of +0.03%. Regarding short-term risk, CERT is more volatile compared to PRVA. This indicates higher risk in terms of short-term price fluctuations for CERT.Check PRVA's competition here
Progyny, Inc. (NASDAQ: PGNY)
CERT vs PGNY Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, PGNY has a market cap of 2.5B. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while PGNY trades at $32.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas PGNY's P/E ratio is 23.53. In terms of profitability, CERT's ROE is -0.01%, compared to PGNY's ROE of +0.13%. Regarding short-term risk, CERT is more volatile compared to PGNY. This indicates higher risk in terms of short-term price fluctuations for CERT.Check PGNY's competition here
Heartflow, Inc. Common Stock (NASDAQ: HTFL)
CERT vs HTFL Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, HTFL has a market cap of 2.2B. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while HTFL trades at $25.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas HTFL's P/E ratio is -12.66. In terms of profitability, CERT's ROE is -0.01%, compared to HTFL's ROE of +8.30%. Regarding short-term risk, CERT is less volatile compared to HTFL. This indicates lower risk in terms of short-term price fluctuations for CERT.Check HTFL's competition here
GeneDx Holdings Corp. (NASDAQ: WGS)
CERT vs WGS Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, WGS has a market cap of 1.8B. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while WGS trades at $61.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas WGS's P/E ratio is 72.53. In terms of profitability, CERT's ROE is -0.01%, compared to WGS's ROE of -0.28%. Regarding short-term risk, CERT is less volatile compared to WGS. This indicates lower risk in terms of short-term price fluctuations for CERT.Check WGS's competition here
Teladoc Health, Inc. (NYSE: TDOC)
CERT vs TDOC Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, TDOC has a market cap of 1.8B. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while TDOC trades at $9.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas TDOC's P/E ratio is -10.79. In terms of profitability, CERT's ROE is -0.01%, compared to TDOC's ROE of -0.12%. Regarding short-term risk, CERT is less volatile compared to TDOC. This indicates lower risk in terms of short-term price fluctuations for CERT.Check TDOC's competition here
NextGen Healthcare, Inc. (NASDAQ: NXGN)
CERT vs NXGN Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, NXGN has a market cap of 1.6B. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while NXGN trades at $23.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas NXGN's P/E ratio is -266.00. In terms of profitability, CERT's ROE is -0.01%, compared to NXGN's ROE of -0.01%. Regarding short-term risk, CERT is more volatile compared to NXGN. This indicates higher risk in terms of short-term price fluctuations for CERT.Check NXGN's competition here
Agiliti, Inc. (NYSE: AGTI)
CERT vs AGTI Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, AGTI has a market cap of 1.4B. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while AGTI trades at $10.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas AGTI's P/E ratio is -71.79. In terms of profitability, CERT's ROE is -0.01%, compared to AGTI's ROE of -0.02%. Regarding short-term risk, CERT is more volatile compared to AGTI. This indicates higher risk in terms of short-term price fluctuations for CERT.Check AGTI's competition here
Omada Health (NASDAQ: OMDA)
CERT vs OMDA Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, OMDA has a market cap of 1.4B. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while OMDA trades at $22.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas OMDA's P/E ratio is 328.43. In terms of profitability, CERT's ROE is -0.01%, compared to OMDA's ROE of -0.03%. Regarding short-term risk, CERT is less volatile compared to OMDA. This indicates lower risk in terms of short-term price fluctuations for CERT.Check OMDA's competition here
GoodRx Holdings, Inc. (NASDAQ: GDRX)
CERT vs GDRX Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, GDRX has a market cap of 1B. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while GDRX trades at $3.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas GDRX's P/E ratio is 9.15. In terms of profitability, CERT's ROE is -0.01%, compared to GDRX's ROE of +0.03%. Regarding short-term risk, CERT is less volatile compared to GDRX. This indicates lower risk in terms of short-term price fluctuations for CERT.Check GDRX's competition here
CareCloud, Inc. (NASDAQ: CCLDO)
CERT vs CCLDO Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, CCLDO has a market cap of 857.3M. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while CCLDO trades at $27.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas CCLDO's P/E ratio is N/A. In terms of profitability, CERT's ROE is -0.01%, compared to CCLDO's ROE of +0.17%. Regarding short-term risk, CERT is more volatile compared to CCLDO. This indicates higher risk in terms of short-term price fluctuations for CERT.Check CCLDO's competition here
HealthStream, Inc. (NASDAQ: HSTM)
CERT vs HSTM Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, HSTM has a market cap of 813.4M. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while HSTM trades at $27.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas HSTM's P/E ratio is 36.63. In terms of profitability, CERT's ROE is -0.01%, compared to HSTM's ROE of +0.06%. Regarding short-term risk, CERT is more volatile compared to HSTM. This indicates higher risk in terms of short-term price fluctuations for CERT.Check HSTM's competition here
Evolent Health, Inc. (NYSE: EVH)
CERT vs EVH Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, EVH has a market cap of 656.9M. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while EVH trades at $5.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas EVH's P/E ratio is 584.00. In terms of profitability, CERT's ROE is -0.01%, compared to EVH's ROE of -0.78%. Regarding short-term risk, CERT is less volatile compared to EVH. This indicates lower risk in terms of short-term price fluctuations for CERT.Check EVH's competition here
Phreesia, Inc. (NYSE: PHR)
CERT vs PHR Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, PHR has a market cap of 654.6M. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while PHR trades at $10.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas PHR's P/E ratio is 37.82. In terms of profitability, CERT's ROE is -0.01%, compared to PHR's ROE of +0.03%. Regarding short-term risk, CERT is less volatile compared to PHR. This indicates lower risk in terms of short-term price fluctuations for CERT.Check PHR's competition here
MultiPlan Corporation (NYSE: MPLN-WT)
CERT vs MPLN-WT Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, MPLN-WT has a market cap of 625.2M. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while MPLN-WT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas MPLN-WT's P/E ratio is N/A. In terms of profitability, CERT's ROE is -0.01%, compared to MPLN-WT's ROE of +2.06%. Regarding short-term risk, CERT is less volatile compared to MPLN-WT. This indicates lower risk in terms of short-term price fluctuations for CERT.Check MPLN-WT's competition here
Accolade, Inc. (NASDAQ: ACCD)
CERT vs ACCD Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, ACCD has a market cap of 575.6M. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while ACCD trades at $7.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas ACCD's P/E ratio is -3.08. In terms of profitability, CERT's ROE is -0.01%, compared to ACCD's ROE of -0.22%. Regarding short-term risk, CERT is more volatile compared to ACCD. This indicates higher risk in terms of short-term price fluctuations for CERT.Check ACCD's competition here
Sharecare, Inc. (NASDAQ: SHCR)
CERT vs SHCR Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, SHCR has a market cap of 531.8M. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while SHCR trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas SHCR's P/E ratio is -3.76. In terms of profitability, CERT's ROE is -0.01%, compared to SHCR's ROE of -0.25%. Regarding short-term risk, CERT is more volatile compared to SHCR. This indicates higher risk in terms of short-term price fluctuations for CERT.Check SHCR's competition here
GeneDx Holdings Corp. (NASDAQ: WGSWW)
CERT vs WGSWW Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, WGSWW has a market cap of 514.5M. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while WGSWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas WGSWW's P/E ratio is N/A. In terms of profitability, CERT's ROE is -0.01%, compared to WGSWW's ROE of -0.28%. Regarding short-term risk, CERT is less volatile compared to WGSWW. This indicates lower risk in terms of short-term price fluctuations for CERT.Check WGSWW's competition here
Claritev Corporation (NYSE: CTEV)
CERT vs CTEV Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, CTEV has a market cap of 488.4M. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while CTEV trades at $28.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas CTEV's P/E ratio is -2.20. In terms of profitability, CERT's ROE is -0.01%, compared to CTEV's ROE of +2.06%. Regarding short-term risk, CERT is less volatile compared to CTEV. This indicates lower risk in terms of short-term price fluctuations for CERT.Check CTEV's competition here
NRC Health (NASDAQ: NRC)
CERT vs NRC Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, NRC has a market cap of 484.1M. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while NRC trades at $21.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas NRC's P/E ratio is 26.20. In terms of profitability, CERT's ROE is -0.01%, compared to NRC's ROE of +0.57%. Regarding short-term risk, CERT is more volatile compared to NRC. This indicates higher risk in terms of short-term price fluctuations for CERT.Check NRC's competition here
SOPHiA GENETICS S.A. (NASDAQ: SOPH)
CERT vs SOPH Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, SOPH has a market cap of 446.8M. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while SOPH trades at $6.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas SOPH's P/E ratio is -12.50. In terms of profitability, CERT's ROE is -0.01%, compared to SOPH's ROE of -1.41%. Regarding short-term risk, CERT is less volatile compared to SOPH. This indicates lower risk in terms of short-term price fluctuations for CERT.Check SOPH's competition here
SomaLogic, Inc. (NASDAQ: SLGC)
CERT vs SLGC Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, SLGC has a market cap of 396.2M. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while SLGC trades at $2.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas SLGC's P/E ratio is -3.04. In terms of profitability, CERT's ROE is -0.01%, compared to SLGC's ROE of -0.19%. Regarding short-term risk, CERT is less volatile compared to SLGC. This indicates lower risk in terms of short-term price fluctuations for CERT.Check SLGC's competition here
SomaLogic, Inc. (NASDAQ: SLGCW)
CERT vs SLGCW Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, SLGCW has a market cap of 396.2M. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while SLGCW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas SLGCW's P/E ratio is -0.16. In terms of profitability, CERT's ROE is -0.01%, compared to SLGCW's ROE of -0.19%. Regarding short-term risk, CERT is less volatile compared to SLGCW. This indicates lower risk in terms of short-term price fluctuations for CERT.Check SLGCW's competition here
TruBridge, Inc. (NASDAQ: TBRG)
CERT vs TBRG Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, TBRG has a market cap of 393.6M. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while TBRG trades at $26.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas TBRG's P/E ratio is 9.37. In terms of profitability, CERT's ROE is -0.01%, compared to TBRG's ROE of +0.02%. Regarding short-term risk, CERT is more volatile compared to TBRG. This indicates higher risk in terms of short-term price fluctuations for CERT.Check TBRG's competition here
MultiPlan Corporation (NYSE: MPLN)
CERT vs MPLN Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, MPLN has a market cap of 375M. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while MPLN trades at $23.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas MPLN's P/E ratio is -0.23. In terms of profitability, CERT's ROE is -0.01%, compared to MPLN's ROE of +2.06%. Regarding short-term risk, CERT is less volatile compared to MPLN. This indicates lower risk in terms of short-term price fluctuations for CERT.Check MPLN's competition here
Simulations Plus, Inc. (NASDAQ: SLP)
CERT vs SLP Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, SLP has a market cap of 368.7M. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while SLP trades at $18.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas SLP's P/E ratio is 20.72. In terms of profitability, CERT's ROE is -0.01%, compared to SLP's ROE of +0.06%. Regarding short-term risk, CERT is more volatile compared to SLP. This indicates higher risk in terms of short-term price fluctuations for CERT.Check SLP's competition here
Tabula Rasa HealthCare, Inc. (NASDAQ: TRHC)
CERT vs TRHC Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, TRHC has a market cap of 284M. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while TRHC trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas TRHC's P/E ratio is -4.27. In terms of profitability, CERT's ROE is -0.01%, compared to TRHC's ROE of +121.31%. Regarding short-term risk, CERT is more volatile compared to TRHC. This indicates higher risk in terms of short-term price fluctuations for CERT.Check TRHC's competition here
Sema4 Holdings Corp. (NASDAQ: SMFR)
CERT vs SMFR Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, SMFR has a market cap of 246.4M. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while SMFR trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas SMFR's P/E ratio is N/A. In terms of profitability, CERT's ROE is -0.01%, compared to SMFR's ROE of -0.28%. Regarding short-term risk, CERT is less volatile compared to SMFR. This indicates lower risk in terms of short-term price fluctuations for CERT.Check SMFR's competition here
So-Young International Inc. (NASDAQ: SY)
CERT vs SY Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, SY has a market cap of 240.1M. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while SY trades at $1.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas SY's P/E ratio is -5.55. In terms of profitability, CERT's ROE is -0.01%, compared to SY's ROE of -0.16%. Regarding short-term risk, CERT is less volatile compared to SY. This indicates lower risk in terms of short-term price fluctuations for CERT.Check SY's competition here
Spok Holdings, Inc. (NASDAQ: SPOK)
CERT vs SPOK Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, SPOK has a market cap of 222.7M. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while SPOK trades at $10.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas SPOK's P/E ratio is 17.77. In terms of profitability, CERT's ROE is -0.01%, compared to SPOK's ROE of +0.09%. Regarding short-term risk, CERT is more volatile compared to SPOK. This indicates higher risk in terms of short-term price fluctuations for CERT.Check SPOK's competition here
American Well Corporation (NYSE: AMWL)
CERT vs AMWL Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, AMWL has a market cap of 209M. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while AMWL trades at $12.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas AMWL's P/E ratio is -2.41. In terms of profitability, CERT's ROE is -0.01%, compared to AMWL's ROE of -0.35%. Regarding short-term risk, CERT is less volatile compared to AMWL. This indicates lower risk in terms of short-term price fluctuations for CERT.Check AMWL's competition here
Health Catalyst, Inc. (NASDAQ: HCAT)
CERT vs HCAT Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, HCAT has a market cap of 159.6M. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while HCAT trades at $2.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas HCAT's P/E ratio is 10.80. In terms of profitability, CERT's ROE is -0.01%, compared to HCAT's ROE of -1.00%. Regarding short-term risk, CERT is less volatile compared to HCAT. This indicates lower risk in terms of short-term price fluctuations for CERT.Check HCAT's competition here
Computer Programs and Systems, Inc. (NASDAQ: CPSI)
CERT vs CPSI Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, CPSI has a market cap of 133.7M. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while CPSI trades at $9.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas CPSI's P/E ratio is -183.80. In terms of profitability, CERT's ROE is -0.01%, compared to CPSI's ROE of +0.02%. Regarding short-term risk, CERT is less volatile compared to CPSI. This indicates lower risk in terms of short-term price fluctuations for CERT.Check CPSI's competition here
OptimizeRx Corp. (NASDAQ: OPRX)
CERT vs OPRX Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, OPRX has a market cap of 125M. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while OPRX trades at $6.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas OPRX's P/E ratio is 6.11. In terms of profitability, CERT's ROE is -0.01%, compared to OPRX's ROE of +0.05%. Regarding short-term risk, CERT is more volatile compared to OPRX. This indicates higher risk in terms of short-term price fluctuations for CERT.Check OPRX's competition here
Augmedix, Inc. (NASDAQ: AUGX)
CERT vs AUGX Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, AUGX has a market cap of 115.9M. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while AUGX trades at $2.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas AUGX's P/E ratio is -4.99. In terms of profitability, CERT's ROE is -0.01%, compared to AUGX's ROE of -1.55%. Regarding short-term risk, CERT is more volatile compared to AUGX. This indicates higher risk in terms of short-term price fluctuations for CERT.Check AUGX's competition here
CareCloud, Inc. (NASDAQ: CCLD)
CERT vs CCLD Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, CCLD has a market cap of 94.8M. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while CCLD trades at $2.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas CCLD's P/E ratio is 8.26. In terms of profitability, CERT's ROE is -0.01%, compared to CCLD's ROE of +0.17%. Regarding short-term risk, CERT is more volatile compared to CCLD. This indicates higher risk in terms of short-term price fluctuations for CERT.Check CCLD's competition here
Definitive Healthcare Corp. (NASDAQ: DH)
CERT vs DH Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, DH has a market cap of 76.5M. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while DH trades at $0.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas DH's P/E ratio is 2.79. In terms of profitability, CERT's ROE is -0.01%, compared to DH's ROE of -0.67%. Regarding short-term risk, CERT is less volatile compared to DH. This indicates lower risk in terms of short-term price fluctuations for CERT.Check DH's competition here
Forian Inc. (NASDAQ: FORA)
CERT vs FORA Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, FORA has a market cap of 67.8M. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while FORA trades at $2.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas FORA's P/E ratio is -24.11. In terms of profitability, CERT's ROE is -0.01%, compared to FORA's ROE of -0.17%. Regarding short-term risk, CERT is more volatile compared to FORA. This indicates higher risk in terms of short-term price fluctuations for CERT.Check FORA's competition here
CareCloud, Inc. (NASDAQ: CCLDP)
CERT vs CCLDP Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, CCLDP has a market cap of 59.9M. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while CCLDP trades at $19.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas CCLDP's P/E ratio is N/A. In terms of profitability, CERT's ROE is -0.01%, compared to CCLDP's ROE of +0.17%. Regarding short-term risk, CERT is more volatile compared to CCLDP. This indicates higher risk in terms of short-term price fluctuations for CERT.Check CCLDP's competition here
OneMedNet Corporation (NASDAQ: ONMD)
CERT vs ONMD Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, ONMD has a market cap of 37.2M. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while ONMD trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas ONMD's P/E ratio is -4.36. In terms of profitability, CERT's ROE is -0.01%, compared to ONMD's ROE of +0.90%. Regarding short-term risk, CERT is less volatile compared to ONMD. This indicates lower risk in terms of short-term price fluctuations for CERT.Check ONMD's competition here
Science 37 Holdings, Inc. (NASDAQ: SNCE)
CERT vs SNCE Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, SNCE has a market cap of 34.7M. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while SNCE trades at $5.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas SNCE's P/E ratio is -0.27. In terms of profitability, CERT's ROE is -0.01%, compared to SNCE's ROE of -0.47%. Regarding short-term risk, CERT is more volatile compared to SNCE. This indicates higher risk in terms of short-term price fluctuations for CERT.Check SNCE's competition here
Akili, Inc. (NASDAQ: AKLI)
CERT vs AKLI Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, AKLI has a market cap of 34.1M. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while AKLI trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas AKLI's P/E ratio is -0.71. In terms of profitability, CERT's ROE is -0.01%, compared to AKLI's ROE of -0.70%. Regarding short-term risk, CERT is more volatile compared to AKLI. This indicates higher risk in terms of short-term price fluctuations for CERT.Check AKLI's competition here
SHL Telemedicine Ltd. (NASDAQ: SHLT)
CERT vs SHLT Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, SHLT has a market cap of 33.6M. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while SHLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas SHLT's P/E ratio is -3.87. In terms of profitability, CERT's ROE is -0.01%, compared to SHLT's ROE of -0.50%. Regarding short-term risk, CERT is more volatile compared to SHLT. This indicates higher risk in terms of short-term price fluctuations for CERT.Check SHLT's competition here
OneMedNet Corporation (NASDAQ: ONMDW)
CERT vs ONMDW Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, ONMDW has a market cap of 33.2M. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while ONMDW trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas ONMDW's P/E ratio is N/A. In terms of profitability, CERT's ROE is -0.01%, compared to ONMDW's ROE of +0.90%. Regarding short-term risk, CERT is more volatile compared to ONMDW. This indicates higher risk in terms of short-term price fluctuations for CERT.Check ONMDW's competition here
Sharecare, Inc. (NASDAQ: SHCRW)
CERT vs SHCRW Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, SHCRW has a market cap of 32.5M. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while SHCRW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas SHCRW's P/E ratio is -0.00. In terms of profitability, CERT's ROE is -0.01%, compared to SHCRW's ROE of -0.25%. Regarding short-term risk, CERT is less volatile compared to SHCRW. This indicates lower risk in terms of short-term price fluctuations for CERT.Check SHCRW's competition here
EUDA Health Holdings Limited (NASDAQ: EUDA)
CERT vs EUDA Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, EUDA has a market cap of 26.8M. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while EUDA trades at $15.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas EUDA's P/E ratio is -27.08. In terms of profitability, CERT's ROE is -0.01%, compared to EUDA's ROE of +0.70%. Regarding short-term risk, CERT is less volatile compared to EUDA. This indicates lower risk in terms of short-term price fluctuations for CERT.Check EUDA's competition here
Streamline Health Solutions, Inc. (NASDAQ: STRM)
CERT vs STRM Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, STRM has a market cap of 23.2M. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while STRM trades at $5.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas STRM's P/E ratio is -2.40. In terms of profitability, CERT's ROE is -0.01%, compared to STRM's ROE of -0.32%. Regarding short-term risk, CERT is more volatile compared to STRM. This indicates higher risk in terms of short-term price fluctuations for CERT.Check STRM's competition here
Renalytix Plc (NASDAQ: RNLX)
CERT vs RNLX Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, RNLX has a market cap of 22.5M. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while RNLX trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas RNLX's P/E ratio is -0.33. In terms of profitability, CERT's ROE is -0.01%, compared to RNLX's ROE of -6.31%. Regarding short-term risk, CERT is less volatile compared to RNLX. This indicates lower risk in terms of short-term price fluctuations for CERT.Check RNLX's competition here
MSP Recovery, Inc. (NASDAQ: LIFW)
CERT vs LIFW Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, LIFW has a market cap of 22.4M. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while LIFW trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas LIFW's P/E ratio is -0.02. In terms of profitability, CERT's ROE is -0.01%, compared to LIFW's ROE of +1.56%. Regarding short-term risk, CERT is more volatile compared to LIFW. This indicates higher risk in terms of short-term price fluctuations for CERT.Check LIFW's competition here
HeartBeam, Inc. (NASDAQ: BEATW)
CERT vs BEATW Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, BEATW has a market cap of 18M. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while BEATW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas BEATW's P/E ratio is -0.05. In terms of profitability, CERT's ROE is -0.01%, compared to BEATW's ROE of -10.34%. Regarding short-term risk, CERT is more volatile compared to BEATW. This indicates higher risk in terms of short-term price fluctuations for CERT.Check BEATW's competition here
Babylon Holdings Limited (NYSE: BBLN)
CERT vs BBLN Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, BBLN has a market cap of 14.1M. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while BBLN trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas BBLN's P/E ratio is -0.04. In terms of profitability, CERT's ROE is -0.01%, compared to BBLN's ROE of +4.89%. Regarding short-term risk, CERT is less volatile compared to BBLN. This indicates lower risk in terms of short-term price fluctuations for CERT.Check BBLN's competition here
ETAO International Co., Ltd. (NASDAQ: ETAO)
CERT vs ETAO Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, ETAO has a market cap of 9.8M. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while ETAO trades at $1.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas ETAO's P/E ratio is -0.01. In terms of profitability, CERT's ROE is -0.01%, compared to ETAO's ROE of -13.69%. Regarding short-term risk, CERT is less volatile compared to ETAO. This indicates lower risk in terms of short-term price fluctuations for CERT.Check ETAO's competition here
Bullfrog AI Holdings, Inc. Common Stock (NASDAQ: BFRG)
CERT vs BFRG Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, BFRG has a market cap of 7.5M. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while BFRG trades at $0.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas BFRG's P/E ratio is -1.19. In terms of profitability, CERT's ROE is -0.01%, compared to BFRG's ROE of -2.18%. Regarding short-term risk, CERT is less volatile compared to BFRG. This indicates lower risk in terms of short-term price fluctuations for CERT.Check BFRG's competition here
Scienture Holdings, Inc. (NASDAQ: SCNX)
CERT vs SCNX Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, SCNX has a market cap of 6M. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while SCNX trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas SCNX's P/E ratio is -0.15. In terms of profitability, CERT's ROE is -0.01%, compared to SCNX's ROE of -0.00%. Regarding short-term risk, CERT is less volatile compared to SCNX. This indicates lower risk in terms of short-term price fluctuations for CERT.Check SCNX's competition here
UpHealth, Inc. (NYSE: UPH)
CERT vs UPH Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, UPH has a market cap of 5.3M. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while UPH trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas UPH's P/E ratio is -0.07. In terms of profitability, CERT's ROE is -0.01%, compared to UPH's ROE of -1.05%. Regarding short-term risk, CERT is less volatile compared to UPH. This indicates lower risk in terms of short-term price fluctuations for CERT.Check UPH's competition here
UpHealth, Inc. (NYSE: UPH-WT)
CERT vs UPH-WT Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, UPH-WT has a market cap of 5.3M. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while UPH-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas UPH-WT's P/E ratio is N/A. In terms of profitability, CERT's ROE is -0.01%, compared to UPH-WT's ROE of -1.05%. Regarding short-term risk, CERT is less volatile compared to UPH-WT. This indicates lower risk in terms of short-term price fluctuations for CERT.Check UPH-WT's competition here
Mangoceuticals, Inc. (NASDAQ: MGRX)
CERT vs MGRX Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, MGRX has a market cap of 4.8M. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while MGRX trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas MGRX's P/E ratio is -0.35. In terms of profitability, CERT's ROE is -0.01%, compared to MGRX's ROE of -1.21%. Regarding short-term risk, CERT is less volatile compared to MGRX. This indicates lower risk in terms of short-term price fluctuations for CERT.Check MGRX's competition here
Pear Therapeutics, Inc. (NASDAQ: PEAR)
CERT vs PEAR Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, PEAR has a market cap of 4.1M. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while PEAR trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas PEAR's P/E ratio is -0.08. In terms of profitability, CERT's ROE is -0.01%, compared to PEAR's ROE of -0.39%. Regarding short-term risk, CERT is less volatile compared to PEAR. This indicates lower risk in terms of short-term price fluctuations for CERT.Check PEAR's competition here
Pear Therapeutics, Inc. (NASDAQ: PEARW)
CERT vs PEARW Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, PEARW has a market cap of 4.1M. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while PEARW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas PEARW's P/E ratio is -0.00. In terms of profitability, CERT's ROE is -0.01%, compared to PEARW's ROE of -0.39%. Regarding short-term risk, CERT is less volatile compared to PEARW. This indicates lower risk in terms of short-term price fluctuations for CERT.Check PEARW's competition here
Ontrak, Inc. (NASDAQ: OTRK)
CERT vs OTRK Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, OTRK has a market cap of 2.3M. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while OTRK trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas OTRK's P/E ratio is -0.02. In terms of profitability, CERT's ROE is -0.01%, compared to OTRK's ROE of -2.11%. Regarding short-term risk, CERT is more volatile compared to OTRK. This indicates higher risk in terms of short-term price fluctuations for CERT.Check OTRK's competition here
Healthcare Triangle, Inc. (NASDAQ: HCTI)
CERT vs HCTI Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, HCTI has a market cap of 2M. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while HCTI trades at $1.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas HCTI's P/E ratio is -0.22. In terms of profitability, CERT's ROE is -0.01%, compared to HCTI's ROE of -0.68%. Regarding short-term risk, CERT is less volatile compared to HCTI. This indicates lower risk in terms of short-term price fluctuations for CERT.Check HCTI's competition here
CareMax, Inc. (NASDAQ: CMAX)
CERT vs CMAX Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, CMAX has a market cap of 1.6M. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while CMAX trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas CMAX's P/E ratio is -0.00. In terms of profitability, CERT's ROE is -0.01%, compared to CMAX's ROE of -2.01%. Regarding short-term risk, CERT is more volatile compared to CMAX. This indicates higher risk in terms of short-term price fluctuations for CERT.Check CMAX's competition here
VSee Health, Inc. (NASDAQ: VSEE)
CERT vs VSEE Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, VSEE has a market cap of 1.5M. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while VSEE trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas VSEE's P/E ratio is -0.17. In terms of profitability, CERT's ROE is -0.01%, compared to VSEE's ROE of -115.71%. Regarding short-term risk, CERT is less volatile compared to VSEE. This indicates lower risk in terms of short-term price fluctuations for CERT.Check VSEE's competition here
Aclarion, Inc. (NASDAQ: ACON)
CERT vs ACON Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, ACON has a market cap of 1.4M. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while ACON trades at $2.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas ACON's P/E ratio is -0.24. In terms of profitability, CERT's ROE is -0.01%, compared to ACON's ROE of -0.54%. Regarding short-term risk, CERT is less volatile compared to ACON. This indicates lower risk in terms of short-term price fluctuations for CERT.Check ACON's competition here
MSP Recovery, Inc. (NASDAQ: LIFWZ)
CERT vs LIFWZ Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, LIFWZ has a market cap of 1.3M. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while LIFWZ trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas LIFWZ's P/E ratio is N/A. In terms of profitability, CERT's ROE is -0.01%, compared to LIFWZ's ROE of +1.56%. Regarding short-term risk, CERT is more volatile compared to LIFWZ. This indicates higher risk in terms of short-term price fluctuations for CERT.Check LIFWZ's competition here
VSee Health, Inc. (NASDAQ: VSEEW)
CERT vs VSEEW Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, VSEEW has a market cap of 1.2M. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while VSEEW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas VSEEW's P/E ratio is -0.04. In terms of profitability, CERT's ROE is -0.01%, compared to VSEEW's ROE of -115.71%. Regarding short-term risk, CERT is less volatile compared to VSEEW. This indicates lower risk in terms of short-term price fluctuations for CERT.Check VSEEW's competition here
EUDA Health Holdings Limited (NASDAQ: EUDAW)
CERT vs EUDAW Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, EUDAW has a market cap of 926.3K. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while EUDAW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas EUDAW's P/E ratio is 0.03. In terms of profitability, CERT's ROE is -0.01%, compared to EUDAW's ROE of +0.70%. Regarding short-term risk, CERT is more volatile compared to EUDAW. This indicates higher risk in terms of short-term price fluctuations for CERT.Check EUDAW's competition here
SCWorx Corp. (NASDAQ: WORX)
CERT vs WORX Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, WORX has a market cap of 602.8K. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while WORX trades at $0.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas WORX's P/E ratio is -0.66. In terms of profitability, CERT's ROE is -0.01%, compared to WORX's ROE of -0.65%. Regarding short-term risk, CERT is more volatile compared to WORX. This indicates higher risk in terms of short-term price fluctuations for CERT.Check WORX's competition here
MSP Recovery, Inc. (NASDAQ: MSPRZ)
CERT vs MSPRZ Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, MSPRZ has a market cap of 550.4K. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while MSPRZ trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas MSPRZ's P/E ratio is N/A. In terms of profitability, CERT's ROE is -0.01%, compared to MSPRZ's ROE of +1.56%. Regarding short-term risk, CERT is less volatile compared to MSPRZ. This indicates lower risk in terms of short-term price fluctuations for CERT.Check MSPRZ's competition here
Akerna Corp. (NASDAQ: KERN)
CERT vs KERN Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, KERN has a market cap of 162.3K. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while KERN trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas KERN's P/E ratio is -0.01. In terms of profitability, CERT's ROE is -0.01%, compared to KERN's ROE of -0.17%. Regarding short-term risk, CERT is less volatile compared to KERN. This indicates lower risk in terms of short-term price fluctuations for CERT.Check KERN's competition here
Akerna Corp. (NASDAQ: KERNW)
CERT vs KERNW Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, KERNW has a market cap of 162.3K. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while KERNW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas KERNW's P/E ratio is -0.00. In terms of profitability, CERT's ROE is -0.01%, compared to KERNW's ROE of -0.17%. Regarding short-term risk, CERT is less volatile compared to KERNW. This indicates lower risk in terms of short-term price fluctuations for CERT.Check KERNW's competition here
MSP Recovery, Inc. (NASDAQ: LIFWW)
CERT vs LIFWW Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, LIFWW has a market cap of 60.1K. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while LIFWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas LIFWW's P/E ratio is N/A. In terms of profitability, CERT's ROE is -0.01%, compared to LIFWW's ROE of +1.56%. Regarding short-term risk, CERT is more volatile compared to LIFWW. This indicates higher risk in terms of short-term price fluctuations for CERT.Check LIFWW's competition here
Zhongchao Inc. (NASDAQ: ZCMD)
CERT vs ZCMD Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, ZCMD has a market cap of 51.1K. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while ZCMD trades at $1.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas ZCMD's P/E ratio is -0.05. In terms of profitability, CERT's ROE is -0.01%, compared to ZCMD's ROE of -0.32%. Regarding short-term risk, CERT is less volatile compared to ZCMD. This indicates lower risk in terms of short-term price fluctuations for CERT.Check ZCMD's competition here
CareMax, Inc. (NASDAQ: CMAXW)
CERT vs CMAXW Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, CMAXW has a market cap of 36.4K. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while CMAXW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas CMAXW's P/E ratio is N/A. In terms of profitability, CERT's ROE is -0.01%, compared to CMAXW's ROE of -2.01%. Regarding short-term risk, CERT is more volatile compared to CMAXW. This indicates higher risk in terms of short-term price fluctuations for CERT.Check CMAXW's competition here
Aclarion, Inc. (NASDAQ: ACONW)
CERT vs ACONW Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, ACONW has a market cap of 11.2K. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while ACONW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas ACONW's P/E ratio is N/A. In terms of profitability, CERT's ROE is -0.01%, compared to ACONW's ROE of -0.54%. Regarding short-term risk, CERT is less volatile compared to ACONW. This indicates lower risk in terms of short-term price fluctuations for CERT.Check ACONW's competition here
CareCloud, Inc. (NASDAQ: MTBCO)
CERT vs MTBCO Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, MTBCO has a market cap of 0. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while MTBCO trades at $25.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas MTBCO's P/E ratio is N/A. In terms of profitability, CERT's ROE is -0.01%, compared to MTBCO's ROE of +0.17%. Regarding short-term risk, CERT is more volatile compared to MTBCO. This indicates higher risk in terms of short-term price fluctuations for CERT.Check MTBCO's competition here
Affymetrix, Inc. (NASDAQ: AFFX)
CERT vs AFFX Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, AFFX has a market cap of 0. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while AFFX trades at $14.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas AFFX's P/E ratio is N/A. In terms of profitability, CERT's ROE is -0.01%, compared to AFFX's ROE of +0.03%. Regarding short-term risk, CERT is more volatile compared to AFFX. This indicates higher risk in terms of short-term price fluctuations for CERT.Check AFFX's competition here
CareCloud, Inc. (NASDAQ: MTBCP)
CERT vs MTBCP Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, MTBCP has a market cap of 0. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while MTBCP trades at $26.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas MTBCP's P/E ratio is N/A. In terms of profitability, CERT's ROE is -0.01%, compared to MTBCP's ROE of +0.17%. Regarding short-term risk, CERT is more volatile compared to MTBCP. This indicates higher risk in terms of short-term price fluctuations for CERT.Check MTBCP's competition here
CareCloud, Inc. (NASDAQ: MTBC)
CERT vs MTBC Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, MTBC has a market cap of 0. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while MTBC trades at $3.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas MTBC's P/E ratio is N/A. In terms of profitability, CERT's ROE is -0.01%, compared to MTBC's ROE of +0.17%. Regarding short-term risk, CERT is less volatile compared to MTBC. This indicates lower risk in terms of short-term price fluctuations for CERT.Check MTBC's competition here
Change Healthcare Inc. (NASDAQ: CHNG)
CERT vs CHNG Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, CHNG has a market cap of 0. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while CHNG trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas CHNG's P/E ratio is -152.72. In terms of profitability, CERT's ROE is -0.01%, compared to CHNG's ROE of -0.05%. Regarding short-term risk, CERT is more volatile compared to CHNG. This indicates higher risk in terms of short-term price fluctuations for CERT.Check CHNG's competition here
Change Healthcare Inc. (NASDAQ: CHNGU)
CERT vs CHNGU Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, CHNGU has a market cap of 0. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while CHNGU trades at $73.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas CHNGU's P/E ratio is N/A. In terms of profitability, CERT's ROE is -0.01%, compared to CHNGU's ROE of -0.05%. Regarding short-term risk, CERT is more volatile compared to CHNGU. This indicates higher risk in terms of short-term price fluctuations for CERT.Check CHNGU's competition here
Cue Health Inc. (NASDAQ: HLTH)
CERT vs HLTH Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, HLTH has a market cap of 0. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while HLTH trades at $25.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas HLTH's P/E ratio is N/A. In terms of profitability, CERT's ROE is -0.01%, compared to HLTH's ROE of +0.00%. Regarding short-term risk, CERT is more volatile compared to HLTH. This indicates higher risk in terms of short-term price fluctuations for CERT.Check HLTH's competition here
Convey Health Solutions Holdings, Inc. (NYSE: CNVY)
CERT vs CNVY Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, CNVY has a market cap of 0. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while CNVY trades at $10.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas CNVY's P/E ratio is -71.50. In terms of profitability, CERT's ROE is -0.01%, compared to CNVY's ROE of -0.02%. Regarding short-term risk, CERT is more volatile compared to CNVY. This indicates higher risk in terms of short-term price fluctuations for CERT.Check CNVY's competition here
Nava Health MD, LLC (NASDAQ: NAVA)
CERT vs NAVA Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, NAVA has a market cap of 0. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while NAVA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas NAVA's P/E ratio is N/A. In terms of profitability, CERT's ROE is -0.01%, compared to NAVA's ROE of +0.15%. Regarding short-term risk, CERT is not fully comparable compared to NAVA. This indicates unavailable risk data in terms of short-term price fluctuations for CERT.Check NAVA's competition here
Cerner Corporation (NASDAQ: CERN)
CERT vs CERN Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, CERN has a market cap of 0. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while CERN trades at $94.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas CERN's P/E ratio is 55.84. In terms of profitability, CERT's ROE is -0.01%, compared to CERN's ROE of +0.14%. Regarding short-term risk, CERT is more volatile compared to CERN. This indicates higher risk in terms of short-term price fluctuations for CERT.Check CERN's competition here
Castlight Health, Inc. (NYSE: CSLT)
CERT vs CSLT Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, CSLT has a market cap of 0. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while CSLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas CSLT's P/E ratio is -37.27. In terms of profitability, CERT's ROE is -0.01%, compared to CSLT's ROE of -0.42%. Regarding short-term risk, CERT is more volatile compared to CSLT. This indicates higher risk in terms of short-term price fluctuations for CERT.Check CSLT's competition here
NantHealth, Inc. (NASDAQ: NH)
CERT vs NH Comparison July 2026
Certara, Inc. (NASDAQ: CERT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERT stands at 1.1B. In comparison, NH has a market cap of 0. Regarding current trading prices, CERT is priced at $6.85 on the NASDAQ, while NH trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERT currently has a P/E ratio of 17.56, whereas NH's P/E ratio is -0.12. In terms of profitability, CERT's ROE is -0.01%, compared to NH's ROE of +0.35%. Regarding short-term risk, CERT is less volatile compared to NH. This indicates lower risk in terms of short-term price fluctuations for CERT.Check NH's competition here